Open Access Open Access  Restricted Access Subscription Access
Cover Image

COVID-19 in South Korea: Usefulness of Antibody test for effective Prevention measures

Insuk Sim, Yun-Jung Kang, Dai-Joong Kim

Abstract


The new coronavirus infection, which began in December 2019, has spread rapidly across Asian countries from January to February 2020 and after March. The disease caused by this virus is called coronavirus disease 2019 (COVID-19) and is characterized by fever, cough, and dyspnea. On January 31, 2020, the World Health Organization (WHO) declared the Public Health Emergency of International Concern. Quarantine authorities are constantly working to prevent the spread of COVID-19. One of the efforts is preparing for a national antibody test as a massive infection is expected to happen again in the fall. There are three reasons for antibody testing from the perspective of prevention measures.First, to find infected people without symptoms. Second, it is to check whether a neutralizing antibody is formed. Third, to confirm collective immunity. Considering the situation where there are no effective antiviral drugs or vaccines, the strategy of establishing an effective countermeasure against antibody tests is a method to minimize the damages of the COVID-19 epidemic that we can currently choose.

Keywords


Antibody test, Collective immunity, COVID-19, Neutralizing antibody, Without symptoms

Full Text:

PDF

References


Su S, Wong G, Shi W, et al. (2016). Epidemiology, genetic recombination, and pathogenesis of coronaviruses. Trends Microbiol. 24(6):490-502. doi:10.1016/j.tim.2016.03.003

Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y et al. (2020). Clinical features of patients infected with 2019 novel coronavirus in Wuhan China. The Lancet. 395: 497-506.

Chan JF, Yuan S, Kok KH, et al. A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating per- son-to-person transmission: a study of a family cluster. Lancet 2020;395:514-523.

World Health Organization. WHO director-general's opening remarks at the media briefing on COVID-19 [Internet]. Geneva (CH): World Health Organization, c2020 [cited 2020Mar 15]. Available from: https://www.who.int/dg/speeches/detail/ who-director-general-s-opening-remarks-at-the-mediabriefing-on-covid-19---11-march-2020.

Lauer SA, Grantz KH, Bi Q, et al. (2020). The incubation period of coronavirus disease 2019 (COVID-19) from publicly reported confirmed cases: estimation and application. Annals Intern Med 2020 Mar 10 [Epub]. Available from: https://doi.org/ 10. 7326/M 20-0504.

Wu Z, McGoogan JM. (2020). Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72 314 cases from the Chinese Center for Disease Control and Prevention. JAMA 2020 Feb 24 [Epub]. Available from: https://doi.org/10.1001/jama.2020.2648.

Park JY. (2020). "Corona Corresponds to Korea, Being Caught by Sinchon and Conservatives". New 1; 2020 Feb 29 [cited 2020 Mar 6]. Available from: https://www.news1.kr/articles/?3858187 (Korean).

Japanese National Institute of Infectious Diseases. Field briefing: diamond princess COVID-19 cases, 20 Feb Update [Internet]. Tokyo (JP): Japanese National Institute of Infectious Diseases, c2020 [cited 2020 Mar 15]. Available from: https://www.niid.go.jp/niid/en/2019-ncov-e/9417-covid-dp-fe-02.html.

European Centre for Disease Prevention and Control. Rapid risk assessment: novel coronavirus disease 2019 (COVID-19) pandemic: increased transmission in the EU/EEA and the UK – sixth update [Internet]. Stockholm (SE): European Centre for Disease Prevention and Control, c2020 [cited 2020 Mar 15]. Available from: https://www.ecdc.europa.eu/en/publicationsdata/ rapid-risk-assessment-novel-coronavirus-disease- 2019-covid-19-pandemic-increased.


Refbacks

  • There are currently no refbacks.